Utah Medical Products (NASDAQ:UTMD) Shares Cross Below Two Hundred Day Moving Average of $93.54

Utah Medical Products, Inc. (NASDAQ:UTMD)’s stock price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $93.54 and traded as low as $83.99. Utah Medical Products shares last traded at $85.65, with a volume of 13,854 shares changing hands.

Analyst Upgrades and Downgrades

Separately, StockNews.com began coverage on shares of Utah Medical Products in a report on Thursday, August 17th. They issued a “buy” rating for the company.

Utah Medical Products Stock Up 2.1 %

The firm has a market cap of $310.91 million, a price-to-earnings ratio of 18.07 and a beta of 0.23. The business’s fifty day moving average is $93.26 and its two-hundred day moving average is $93.54.

Utah Medical Products (NASDAQ:UTMD) last announced its quarterly earnings data on Tuesday, July 25th. The medical instruments supplier reported $1.15 EPS for the quarter. The firm had revenue of $12.87 million during the quarter. Utah Medical Products had a return on equity of 14.93% and a net margin of 33.22%.

Utah Medical Products Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, October 3rd. Shareholders of record on Friday, September 15th will be issued a dividend of $0.295 per share. This represents a $1.18 dividend on an annualized basis and a yield of 1.38%. The ex-dividend date of this dividend is Thursday, September 14th. Utah Medical Products’s dividend payout ratio is presently 24.89%.

Institutional Trading of Utah Medical Products

Institutional investors have recently bought and sold shares of the business. JPMorgan Chase & Co. grew its holdings in shares of Utah Medical Products by 16.9% in the 1st quarter. JPMorgan Chase & Co. now owns 101,769 shares of the medical instruments supplier’s stock valued at $9,145,000 after buying an additional 14,693 shares during the period. Bank of New York Mellon Corp grew its position in shares of Utah Medical Products by 2.0% in the 1st quarter. Bank of New York Mellon Corp now owns 19,948 shares of the medical instruments supplier’s stock valued at $1,793,000 after purchasing an additional 389 shares during the period. Acadian Asset Management LLC acquired a new position in shares of Utah Medical Products in the 1st quarter valued at approximately $40,000. MetLife Investment Management LLC grew its position in shares of Utah Medical Products by 57.0% in the 1st quarter. MetLife Investment Management LLC now owns 2,030 shares of the medical instruments supplier’s stock valued at $182,000 after purchasing an additional 737 shares during the period. Finally, Panagora Asset Management Inc. grew its position in shares of Utah Medical Products by 36.8% in the 1st quarter. Panagora Asset Management Inc. now owns 6,782 shares of the medical instruments supplier’s stock valued at $609,000 after purchasing an additional 1,824 shares during the period. Institutional investors and hedge funds own 70.35% of the company’s stock.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.